ConductScience.org, home

Paper21531982

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.

Klampfl T and 18 others. Blood, 2011. Cited by 153 papers, by iCite.

Cite this record

ConductScience Library. Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Papers, record 21531982. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21531982

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.
PubMed
Journal
Blood
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
153
iCite
Relative citation ratio, by iCite
3.42
iCite
Revised in PubMed
2022-03-31
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klampfl TThorsten
2Harutyunyan AAshot
3Berg TTiina
4Gisslinger BBettina
5Schalling MMartin
6Bagienski KKlaudia
7Olcaydu DDamla
8Passamonti FFrancesco
9Rumi EElisa
10Pietra DDaniela
11Jäger RRoland
12Pieri LLisa
13Guglielmelli PPaola
14Iacobucci IIlaria
15Martinelli GGiovanni
16Cazzola MMario
17Vannucchi AMAlessandro M
18Gisslinger HHeinz
19Kralovics RRobert

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genome-Wide Association StudyMajor topic
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeMajor topic
Myeloproliferative DisordersMajor topic
Oligonucleotide Array Sequence AnalysisMajor topic
Chronic Disease
Disease Progression
Gene Expression Regulation, Leukemic
Humans
Janus Kinase 2
Karyotyping
Point Mutation
Polymorphism, Single Nucleotide

Source PubMed

Download CSV of topics

Cited by92

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.

PMIDTitleJournalYearIn PapersSource
42448935IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms.Leukemia2026https://conductscience.org/library/papers/42448935PubMed
42279423SNP-Based Chromosomal Microarray Analysis in the Era of Optical Genome Mapping: An Enriched Case-Series Evaluating Copy-Neutral Events.Cancers (Basel)2026https://conductscience.org/library/papers/42279423PubMed
41939253Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation.Hemasphere2026https://conductscience.org/library/papers/41939253PubMed
41717866Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study.Eur J Haematol2026https://conductscience.org/library/papers/41717866PubMed
41212396The molecular management of classic myeloproliferative neoplasm.J Egypt Natl Canc Inst2025https://conductscience.org/library/papers/41212396PubMed
40542832Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort study.Ann Hematol2025https://conductscience.org/library/papers/40542832PubMed
40490510Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A.Nat Genet2025https://conductscience.org/library/papers/40490510PubMed
40164719Whole-genome sequencing of myeloproliferative neoplasms revealed dynamic clonal changes in the fibrotic or leukemic transformation and novel FOXP1 mutations in the fibrotic transformation.Leukemia2025https://conductscience.org/library/papers/40164719PubMed
40163809Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML.Blood2025https://conductscience.org/library/papers/40163809PubMed
40076747High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression.Int J Mol Sci2025https://conductscience.org/library/papers/40076747PubMed
39598101Myeloproliferative Neoplasms: Challenging Dogma.J Clin Med2024https://conductscience.org/library/papers/39598101PubMed
38605095Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics.Sci Rep2024https://conductscience.org/library/papers/38605095PubMed
38308077Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms.Sci Rep2024https://conductscience.org/library/papers/38308077PubMed
38135698STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient.Cancer Gene Ther2024https://conductscience.org/library/papers/38135698PubMed
37684235Shared and distinct genetic etiologies for different types of clonal hematopoiesis.Nat Commun2023https://conductscience.org/library/papers/37684235PubMed
37564898Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges.Ther Adv Hematol2023https://conductscience.org/library/papers/37564898PubMed
36845951Sclerosing extramedullary hematopoietic tumor of the colon: A case report and literature review.Exp Ther Med2023https://conductscience.org/library/papers/36845951PubMed
36834692IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?Int J Mol Sci2023https://conductscience.org/library/papers/36834692PubMed
36632576Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies.J Hematol2022https://conductscience.org/library/papers/36632576PubMed
36568246Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management.Front Oncol2022https://conductscience.org/library/papers/36568246PubMed

See all 92 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CUX11523PubTator's text mininghttps://conductscience.org/library/genes/1523NCBI Gene
ETV62120PubTator's text mininghttps://conductscience.org/library/genes/2120NCBI Gene
FOXP127086PubTator's text mininghttps://conductscience.org/library/genes/27086NCBI Gene
IKZF110320PubTator's text mininghttps://conductscience.org/library/genes/10320NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
RUNX1861PubTator's text mininghttps://conductscience.org/library/genes/861NCBI Gene
TET254790PubTator's text mininghttps://conductscience.org/library/genes/54790NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21531982

GET https://conductscience.org/api/papers/v1/21531982/cited_by?page=2